Company Overview
- Website
- carminetherapeutics.com
- Phone
- (617) 459-3608
- Employees
- 9
- Founded in
- 2019
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Primary Ciliary Dyskinesia drugs in development by stages, target, MoA, RoA, molecule type and key players, 2024
- Sep 27, 2024
- pharmaceutical-technology.com
Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer
- Sep 19, 2024
- sciencedirect.com
IL‐12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer
- Aug 28, 2024
- onlinelibrary.wiley.com
Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia
- May 3, 2023
- sciencedirect.com
Takeda taking magnifying glass to non-viral gene therapy programs as Carmine pact ends
- Apr 12, 2023
- endpoints.news
Carmine Therapeutics Announces First Close of Series A to Develop Next generation, Non-viral gene therapy
- Oct 13, 2022
- prnewswire.com
Who is Carmine Therapeutics
Carmine Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts. Founded in 2019, the company employs 9 people. Carmine Therapeutics specializes in developing non-viral gene therapies utilizing red blood cell extracellular vesicles. Their therapies incorporate proprietary payloads, offering a novel approach to gene delivery. The company's focus lies in partnering with pharmaceutical giants like Takeda Pharmaceuticals, with whom they have secured a research alliance potentially reaching $900 million. Recognized for its groundbreaking work, Carmine Therapeutics has been named one of FierceBiotech’s Fierce 15 Biotech companies of 2020 and awarded the Bristol-Myers Squibb "Golden Ticket." The company's leadership boasts experienced figures in the biotechnology industry, including Professor Harvey Lodish, a founding member of successful biotechs Genzyme and Millennium Pharmaceuticals. For media inquiries, please contact [email protected]. Investor relations inquiries can be directed to [email protected].
Carmine Therapeutics Tech Stack
Companies Similar to Carmine Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Carmine Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |